Virtusa Recognized as Enterprise Innovator in HFS Horizons: HCP Service Providers, 2024 Report
Virtusa is positioned as a Horizon 2 – Enterprise Innovator in the HFS Horizons Report, highlighting its ability to support...
Month: July 2024
Syra Health Shares its Artificial Intelligence (AI) to Protect Privacy by Redacting Personally Identifiable Information
CARMEL, Ind., July 16, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology...
Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics
MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety...
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland and...
Montrose Environmental Group Implements Proprietary Technology to Address Colorado Air Monitoring Regulations
LITTLE ROCK, Ark., July 16, 2024 /PRNewswire/ -- Montrose Environmental Group, Inc. ("Montrose" or "the Company") (NYSE: MEG), a high-growth...
AmeriCare Medical Honored by the State of Michigan for Exceptional Work in Home Care
TROY, Mich., July 16, 2024 /PRNewswire/ -- AmeriCare Medical, Inc., a leading provider of home healthcare services, has received recognition...
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
ST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday,...
Globally Unique VELA Mammography Chair, Offered by Enable Me, is an Exciting New High-Tech Tool in the Fight Against Breast Cancer
See the VELA Mammography Chair in action for the first time in Booth 208 at the Florida Radiological Association and...
Exclusive Interview With Zafer ElKhatib – Physiowell’s Co-Founder: Vision and Values
Zafer's Vision: Transforming Rehabilitation in Dubai with PhysiowellDUBAI, UAE / ACCESSWIRE / July 16, 2024 / Physiowell has established itself...
Odyssey Behavioral Healthcare’s 2023 Clinical Outcomes Report Identifies Notable Symptom Improvement From Treatment
BRENTWOOD, TN / ACCESSWIRE / July 16, 2024 / Odyssey Behavioral Healthcare ("Odyssey"), a leading provider of mental health, addiction,...
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17th at 4:00 PM ET HOUSTON, TX /...
Health eCareers Announces Launch of ‘Vital Signs’
New career-focused magazine helps employers, educators, and brands reach nurses nationwide.NEW YORK, NY / ACCESSWIRE / July 16, 2024 /...
Avant Brands Announces $3.9 Million Private Placement of Unsecured Convertible Debenture Units
KELOWNA, BC / ACCESSWIRE / July 16, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
STUDIO CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the...
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs...
Senti Bio Announces Reverse Stock Split
Shares expected to begin trading on split-adjusted basis on July 18, 2024SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE)...
CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
Reimbursement expected to accelerate medical site activations and cover a portion of the Company’s NEUTRALIZE-AKI trial costs DENVER, July 16,...
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals...
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
DALLAS, TX, July 16, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on...
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing...